BioMarin Pharma (BMRN) Receives Standard Approval for Palynziq Injection for Treatment of Adults with Phenylketonuria
Tweet Send to a Friend
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that BioMarin received standard approval from the U.S. Food and Drug Administration (FDA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
